Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00211926
Status:
COMPLETED
Last Update Posted:
2008-01-04
First Post:
2005-09-13
Brief Title:
StaphVAX Immunogenicity in Orthopedic Implant Patients
Sponsor:
Nabi Biopharmaceuticals
Organization:
Nabi Biopharmaceuticals
Organization Data
Organization:
Nabi Biopharmaceuticals
Class:
INDUSTRY
Study ID:
Nabi-1365
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Nabi Biopharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Matt Hohenboken MD PhD Executive Director Clinical and Medical Affairs
Old Organization:
Nabi Biopharmaceuticals